Skip to main content
spacbrain
The briefWednesday, 15 July 2026Updated 23:59 GMT

What changed on 15 July 2026

Also on the diary

11 dated events this weekWhat to do about them
  • HUDA Redemption deadline Wed 15 Jul · broker cutoff Mon 13 Jul
  • MBAV Redemption deadline Wed 15 Jul · broker cutoff Mon 13 Jul
  • CEPO Outside date Thu 16 Jul · long-stop
  • HUDA Extension vote Fri 17 Jul · broker cutoff Wed 15 Jul
  • MBAV Extension vote Fri 17 Jul · broker cutoff Wed 15 Jul
  • NOEM Redemption deadline Fri 17 Jul · broker cutoff Wed 15 Jul

… and 5 more on the calendar.

A long-stop is the charter’s outside date for completing a combination. It pays nothing: the trust comes back only if no deal closes by then.

Deals

Nothing to report. No deal announcements, votes, approvals or terminations are dated inside this window.

In the filings

8-K filed 2026-07-15 — AEON Biopharma, the Priveterra Acquisition successor, signed an underwriting agreement on July 13, 2026 with Lake Street Capital Markets for a public…

Why it matters: A combined offering price of about 32 cents is the operative number, and the structure compounds it: roughly 42.7 million shares and pre-funded warrants in the base deal, each carrying a two-year and a five-year milestone warrant, struck at $0.3221 and $0.3704, plus the over-allotment. Pre-funded warrants exercise at $0.0001 so they are ….

AEON dossier 0001837607-26-000052opens on sec.gov in a new tab

8-K filed 2026-07-15 — Triller Group Inc., the AGBA Acquisition Ltd successor, disclosed that on July 9, 2026 the Nasdaq Hearings Panel granted an exception to regain compl…

Why it matters: The terms got harder, not easier: twenty consecutive days above $1.00 by July 30, 2026 replaces ten days by June 30, meaning the company missed the earlier deadline and now needs a longer clean run in less time. This company has already been through a delisting determination once, on periodic filing failures, so it is operating without m….

AGBA dossier 0001213900-26-078375opens on sec.gov in a new tab

8-K filed 2026-07-15 — T3 Defense Inc., the Brilliant Acquisition Corp successor, disclosed that on July 12, 2026 SC II Acquisition Corp., a Cayman SPAC whose sponsor SC Ca…

Why it matters: A terminated letter of intent removes the only announced deal path for SC II Acquisition Corp., which returns that SPAC to searching with whatever time remains on its own combination deadline — the usual precursor to an extension vote or liquidation. For T3 Defense holders the interest is indirect but real: the sponsor economics sit insi….

BRLI dossier 0001213900-26-078163opens on sec.gov in a new tab

424B3 filed 2026-07-15 — Prospectus Supplement No. 4 (dated July 14, 2026) to the April 9, 2026 resale prospectus on Form S-1 (No. 333-294802) of the post-combination company…

Why it matters: Confirms the Churchill Capital Corp X / Infleqtion combination has closed and the successor trades on NYSE as INFQ. The registered resale overhang is 121.8 million shares against a stock at $10.45, and Global Frontier's in-kind distribution puts 23.25 million previously locked shares into the hands of individual LPs who face no coordinat….

CCCX dossier 0001193125-26-303734opens on sec.gov in a new tab

8-K filed 2026-07-15 — Churchill Capital Corp IX disclosed that on July 14, 2026 its board determined the company cannot complete a business combination by its charter dead…

Why it matters: This is a confirmed liquidation with a date attached: public holders are cashed out of trust within ten business days of August 6, 2026, and redemption completely extinguishes their rights as shareholders, including any further liquidating distribution. The payout is the trust balance less permitted withdrawals, so the working capital dr….

CCIX dossier 0001193125-26-303455opens on sec.gov in a new tab

DEFA14A filed 2026-07-15 — Senti Biosciences, the Dynamics Special Purpose Corp. successor, filed as additional proxy material the same Agreement and Plan of Merger dated July …

Why it matters: Filing the merger agreement under Schedule 14A as well as on Form 8-K puts it before stockholders as soliciting material, which confirms the transaction goes to a vote rather than being completed by written consent or tender. For holders of the former DYNS equity that vote is the only point of leverage, and the merger consideration and e….

DYNS dossier 0001628280-26-048249opens on sec.gov in a new tab

8-K filed 2026-07-15 — Eos Energy Enterprises, the B. Riley Principal Merger Corp. II successor, issued a press release on July 15, 2026 with preliminary results for the qu…

Why it matters: Revenue tripling on shipments is the growth case, but the margin figure is the one that decides whether it matters: a gross margin loss of 69% to 73% means the company still sells each unit for well under what it costs to build, so more volume increases the cash burn rather than reducing it. Bringing a second line into commercial product….

EOSE dossier 0001628280-26-048253opens on sec.gov in a new tab

S-1/A 2026-07-15 — A routine compliance exhibit filing — specifically, an exhibits-only Amendment No. 3 to Form S-1 Registration Statement under the Securities Act of 1…

Why it matters: As an exhibits-only post-effective amendment, this filing does not alter the prospectus, meaning the trust account mechanics, shareholder redemption terms, and the 2027-08-05 deadline remain exactly as stated in the June 29, 2026 registration statement. The documented reduction of founder shares from approximately 7.4 million to 5,175,00….

FJDI dossier 0001493152-26-033301opens on sec.gov in a new tab

8-K filed 2026-07-15 — MoonLake Immunotherapeutics, the Helix Acquisition Corp successor, reported that on July 10, 2026 the underwriters of its previously announced public…

Why it matters: Full exercise of the greenshoe means the offering was oversubscribed at the pricing level, so demand rather than distress drove this raise — a distinction that matters at a clinical-stage de-SPAC where most equity issuance is defensive. The $30.0 million of extra gross proceeds extends the runway ahead of clinical milestones, at the cost….

HLXA dossier 0001213900-26-078031opens on sec.gov in a new tab

10-Q filed 2026-07-15 — Quarterly Report (Form 10-Q) for the period ended May 31, 2026. First quarterly report since IPO. SPAC raised $230M (23M units at $10.00) plus $6.25M…

Why it matters: SPAC is freshly public with $10.09 trust per share, providing a strong floor for redemptions. With only $0.82M of working capital outside trust, the sponsor likely needs to fund due diligence costs. The $8.05M deferred underwriting fee is payable only upon deal completion. The Q1 filing shows clean mechanics — no redemptions yet, no exte….

ILLU dossier 0001206774-26-000355opens on sec.gov in a new tab

424B4 filed 2026-07-15 — Priced IPO of units at $10.00. Each unit is one Class A ordinary share plus one right to receive one-eighth (1/8) of a Class A ordinary share on cons…

Why it matters: Jones Ventures is a rights-only vehicle, so there is no warrant strike, expiry or warrant redemption trigger to record; a null in those fields is the filed answer rather than a coverage gap. The 21-month deadline runs from closing and is extended only by shareholder approval of an amendment to the memorandum and articles of association. ….

JONE dossier 0001213900-26-078062opens on sec.gov in a new tab

… 16 more not shown (28 in this window).

Redemptions

Nothing to report. No new SEC-sourced redemption results were captured in this window.

New coverage

Nothing to report. No SPACs were added and no decks were extracted in this window.

From the wire

Company wires and the financial press, in this window. Headlines belong to the outlets that wrote them and open on their sites.

The full news feed

How this brief is made

  • Composed deterministically from stored primary-sourced rows — no LLM, no live fetching of facts, $0 per run.
  • Trust NAV accreted at the 3-mo T-bill par yield 4.00% (treasury.gov, 2026-09-10); accreted values are ESTIMATES and labeled as such.
  • Broker action dates count ~2 real NYSE trading days before the deadline (weekends and market holidays excluded) — still verify with your broker, whose cutoff may be earlier.
  • 61 filings were scanned for this window.
  • Dated events are summarised on this page and never turned into an instruction. An outside date is the contractual long-stop: it pays nothing, and the trust comes back only if no combination closes. Where the record holds no dated redemption event either way, the page says so instead of assuming one.

Every figure on this page is taken from a filing with the U.S. Securities and Exchange Commission and links to it. Estimates are labelled as estimates. Prices are last trades, not quotes. This is information, not investment advice.

This is a dated edition — the record of one day, kept at its own address. Editions are retained for 60 days.

Today’s brief